Atlas Trials

Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Two Treatment Modules in Chinese Subjects With Moderate to Severe Crohn's Disease

Clinical trial NCT02015793 · COMPLETED

Trial details

NCT number
NCT02015793
Sponsor
AbbVie
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Crohn's Disease
Start date
2013-12-01
Primary completion
2015-02-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.